首页> 外国专利> cancer treatment method, nk cell activity increase method, innate th1 response or activity increase method, method of treatment of a th2-mediated dysfunction, method of treatment of an immune disease, uses of an antagonist molecule and use of an agonist molecule

cancer treatment method, nk cell activity increase method, innate th1 response or activity increase method, method of treatment of a th2-mediated dysfunction, method of treatment of an immune disease, uses of an antagonist molecule and use of an agonist molecule

机译:癌症治疗方法,nk细胞活性增加方法,先天th1应答或活性增加方法,th2介导的功能障碍的治疗方法,免疫疾病的治疗方法,拮抗剂分子的用途和激动剂分子的用途

摘要

CANCER TREATMENT METHOD, NK CELL ACTIVITY INCREASE METHOD, RESPONSE INCREASE METHOD OR THI INACTA ACTIVITY METHOD, TH2-MEDIATED DIAGNOSIS METHOD AND TREATMENT METHOD OF AN AGONIST MOLECULE. The present invention relates to agonists and antagonists that modulate TWEAK and TWEAK receptor activity. The methods, compositions and kits of the present invention may be employed in the treatment of disorders such as cancer and immune diseases.
机译:癌症治疗方法,NK细胞活性增加方法,响应性增加方法或THI无效活性方法,TH2介导的诊断方法和激动剂分子的治疗方法。本发明涉及调节TWEAK和TWEAK受体活性的激动剂和拮抗剂。本发明的方法,组合物和试剂盒可用于治疗疾病,例如癌症和免疫疾病。

著录项

  • 公开/公告号BRPI0608012A2

    专利类型

  • 公开/公告日2009-11-03

    原文格式PDF

  • 申请/专利权人 GENENTECH INC.;

    申请/专利号BR2006PI08012

  • 发明设计人 AVI J. ASHKENAZI;HEATHER MAECKER;

    申请日2006-03-02

  • 分类号A61K39/395;A61K38/17;A61P35;A61P37/02;C07K14/715;C07K16/28;

  • 国家 BR

  • 入库时间 2022-08-21 19:28:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号